Mary Beth Shirk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary Beth Shirk has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ashley Larrimore
Department of Emergency Medicine, The Ohio State University College of Medicine, Columbus, OH; The Center for Emergency Medical Services, The Ohio State University Wexner Medical Center, Columbus, OH
1 shared publicationEric J. Adkins
Emergency Department, The Ohio State University Wexner Medical Center, Columbus, Ohio
1 shared publicationHannah Hays
B Central Ohio Poison Center , Columbus , OH , USA
1 shared publicationHoward Werman
Department of Emergency Medicine, The Ohio State University College of Medicine, Columbus, OH; MedFlight of Ohio, Columbus, OH
1 shared publicationJill Shirvani
OSUMC
1 shared publicationJose A. Bazan
Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, Ohio
1 shared publication
Latest Publications
- 1 January 2019
- Published by Elsevier in Air Medical Journal
- Vol. 38 (1) , 39-44
Impact of Paralytic Agent on Postintubation Sedation
- 1 January 2019
- Published by Elsevier in Air Medical Journal
- Vol. 38 (1) , 39-44
Impact of Paralytic Agent on Postintubation Sedation
- 1 September 2016
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 51 (9) , 738-743
Evaluation of Pharmacist Impact on Culture Review Process for Patients Discharged from the Emergency Department
Background: Accurate and timely review of microbiological test results is a core component of antimicrobial stewardship. There is documented success of these programs in the inpatient setting; however, emergency department (ED) patients are typically not included in these initiatives. Objectives: To assess the impact of an emergency medicine pharmacist (EMP)–facilitated review process of positive microbiological test results from patients discharged from the ED as measured by time to positive result review and number of indicated interventions completed. Methods: This was a retrospective study that compared EMP-facilitated to ED charge nurse (CN)–facilitated physician review of randomly selected positive microbiological test results. Groups were compared concurrently within the time frame of July 1, 2012 through December 31, 2012. Results: One hundred seventy-eight positive microbiological test results were included (EMP, n = 91; CN, n = 87). The median (IQR) time to initial review was 3 (1.0–6.3) hours for the EMP and 2 (0.3–5.5) hours for the CN group ( p = .35). Four percent (1/25) of indicated interventions were not completed in the EMP group versus 47% (14/30) in the CN group ( p = .0004). Conclusion: An EMP was significantly less likely to miss an intervention when indicated with no difference in time to review of positive microbiological results. These findings support the role of the EMP in antimicrobial stewardship in the ED.
- 1 September 2016
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 51 (9) , 738-743
Evaluation of Pharmacist Impact on Culture Review Process for Patients Discharged from the Emergency Department
Background: Accurate and timely review of microbiological test results is a core component of antimicrobial stewardship. There is documented success of these programs in the inpatient setting; however, emergency department (ED) patients are typically not included in these initiatives. Objectives: To assess the impact of an emergency medicine pharmacist (EMP)–facilitated review process of positive microbiological test results from patients discharged from the ED as measured by time to positive result review and number of indicated interventions completed. Methods: This was a retrospective study that compared EMP-facilitated to ED charge nurse (CN)–facilitated physician review of randomly selected positive microbiological test results. Groups were compared concurrently within the time frame of July 1, 2012 through December 31, 2012. Results: One hundred seventy-eight positive microbiological test results were included (EMP, n = 91; CN, n = 87). The median (IQR) time to initial review was 3 (1.0–6.3) hours for the EMP and 2 (0.3–5.5) hours for the CN group ( p = .35). Four percent (1/25) of indicated interventions were not completed in the EMP group versus 47% (14/30) in the CN group ( p = .0004). Conclusion: An EMP was significantly less likely to miss an intervention when indicated with no difference in time to review of positive microbiological results. These findings support the role of the EMP in antimicrobial stewardship in the ED.
- 21 January 2016
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 54 (3) , 266-270
Characterization of drug overdoses in an Ohio incarcerated population
Context: Literature exists about drug overdose following release of recently incarcerated individuals and mortality among prisoners in the United States, but little information exists about drug overdoses in the imprisoned population. Objective: This study aims to quantify and describe prisoner medication overdose requiring inpatient admission or assessment at a tertiary care facility and to assess the associated hospital charges. Materials and methods: A single-center, retrospective cohort study was conducted on all Ohio Department of Rehabilitation and Correction inmates who presented to The Ohio State University Wexner Medical Center with drug overdose between 15 October 2011 and 14 October 2014. Demographic information, overdose substances, exposure reason, clinical effects, lengths of stay, outcomes, and hospital charges were collected. Results: Of the 130 patients included in the study, there were 100 intentional overdoses, 7 unintentional overdoses, 3 adverse drug reactions, and 20 unknown intentions. The most common drug in prisoner overdose was phenytoin (n = 29, 22%). While anticonvulsants were the most common drug class overall, anticonvulsants, antidepressants, and cardiovascular medications accounted for equal numbers of intensive care unit (ICU) admissions. Most patients exhibited multiple symptoms on arrival, most commonly neurologic, cardiovascular, and gastrointestinal symptoms. Patients were seen from 21 of the 28 Ohio Department of Rehabilitation and Correction facilities, of which five facilities, that largely house minimum and medium security prisoners, accounted for 61% of patients sent to our institution. The total sum of charges was $2,606,942 with 55% of charges from ICU stays. Conclusion: Our study shows that drug overdoses within our incarcerated population were largely intentional overdoses of anticonvulsants, cardiovascular drugs, and antidepressants. Opportunities exist to target intentional drug overdoses that accounted for 80% of prisoner overdoses for potential cost-savings.
- 21 January 2016
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 54 (3) , 266-270
Characterization of drug overdoses in an Ohio incarcerated population
Context: Literature exists about drug overdose following release of recently incarcerated individuals and mortality among prisoners in the United States, but little information exists about drug overdoses in the imprisoned population. Objective: This study aims to quantify and describe prisoner medication overdose requiring inpatient admission or assessment at a tertiary care facility and to assess the associated hospital charges. Materials and methods: A single-center, retrospective cohort study was conducted on all Ohio Department of Rehabilitation and Correction inmates who presented to The Ohio State University Wexner Medical Center with drug overdose between 15 October 2011 and 14 October 2014. Demographic information, overdose substances, exposure reason, clinical effects, lengths of stay, outcomes, and hospital charges were collected. Results: Of the 130 patients included in the study, there were 100 intentional overdoses, 7 unintentional overdoses, 3 adverse drug reactions, and 20 unknown intentions. The most common drug in prisoner overdose was phenytoin (n = 29, 22%). While anticonvulsants were the most common drug class overall, anticonvulsants, antidepressants, and cardiovascular medications accounted for equal numbers of intensive care unit (ICU) admissions. Most patients exhibited multiple symptoms on arrival, most commonly neurologic, cardiovascular, and gastrointestinal symptoms. Patients were seen from 21 of the 28 Ohio Department of Rehabilitation and Correction facilities, of which five facilities, that largely house minimum and medium security prisoners, accounted for 61% of patients sent to our institution. The total sum of charges was $2,606,942 with 55% of charges from ICU stays. Conclusion: Our study shows that drug overdoses within our incarcerated population were largely intentional overdoses of anticonvulsants, cardiovascular drugs, and antidepressants. Opportunities exist to target intentional drug overdoses that accounted for 80% of prisoner overdoses for potential cost-savings.
- 15 September 2006
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 63 (18) , 1704-1716
Unlabeled uses of nebulized medications
Purpose. The uses, dosing recommendations, benefits, and disadvantages of unlabeled drugs administered by nebulization are reviewed.
- 15 September 2006
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 63 (18) , 1704-1716
Unlabeled uses of nebulized medications
Purpose. The uses, dosing recommendations, benefits, and disadvantages of unlabeled drugs administered by nebulization are reviewed.